Catherine Noguès

Biographic Data

ID5929929
NAMECatherine Noguès
GIVEN NAMESCatherine
FAMILY NAMENoguès
SIGNATURENOGUES C
AFFILIATIONSHôpital René Huguenin
VERIFIEDNo
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2011
LATEST PUBLICATION YEAR2017
H-INDEX0

  • How Can Contingent Valuation Inform the Bioethics Debate? Evidence from a Survey on Hereditary Cancers in France

    Christel Protière, Olivier Chanel et al.ARTICLERevue économique2017References: 2

    Les porteurs de la mutation BRCA1/2 ont un risque plus élevé de développer un cancer du sein ou de l’ovaire à un âge plus jeune. Le diagnostic préimplantatoire (DPI) et le diagnostic prénatal (DPN) sont deux des rares options pour éviter de transmettre cette mutation. Afin d’éclairer le débat sur l’autorisation du DPI et du DNP pour les porteurs de cette mutation, les préférences de 460 porteurs sains ont été révélées grâce à une enquête d’évalua…

  • Disclosure of research results

    Open AccessJason Mancini, Julien Mancini et al.ARTICLEHealth Expectations2016

    BACKGROUND: There exist no recommendations as to how aggregate research results should best be disclosed to long-term cohort participants. OBJECTIVE: To study the impact of cohort results disclosure documents of various kinds on participants' satisfaction. DESIGN: Randomized study with a 2x2 factorial design. SETTING AND PARTICIPANTS: The GENEPSO-PS cohort is used to study the psychosocial characteristics and preventive behaviour of both BRCA1/2 …

  • “Maybe they have found something new” participants’ views on returning cohort psychosocial survey results

    Open AccessEve Bureau-Point, Eve Bureau et al.ARTICLEHealth Expectations2015

    BACKGROUND: Although greater attention is currently being paid to participants in research, no studies have dealt so far with the issue of returning aggregate psychosocial results to cohort participants. OBJECTIVE: (i) To explore participants' views about disclosure of the aggregate results of a French national psychosocial cohort survey on the epidemiology of preventive behaviour in women from families with a hereditary breast cancer risk. (ii) …

  • P1-46 Diagnostic radiation exposure and breast cancer risk in BRCA1/2 mutation carriers in the gene-rad-risk study

    Anouk Pijpe, Nadine Andrieu et al.ARTICLEJournal of Epidemiology and…2011

    Introduction BRCA1/2 mutation carriers might be more sensitive to ionising radiation due to impaired DNA repair mechanisms. Methods A retrospective European collaborative cohort study (GENE-RAD-RISK) of 1993 female BRCA1/2 mutation carriers was performed using self-reported exposure to diagnostic radiation. Risk of breast cancer was estimated using a weighted Cox proportional hazards model with cumulative radiation exposure from diagnostic proced…